Journal Watch
-
Nocturnal HD helps people grow cells that lead to healthy new blood vessels
Growth of new blood vessels is impaired with standard in-center HD. The cells that grow blood vessels don't work as well as they should, because waste levels in the blood are still too high, even with treatment. But, nocturnal HD is another story. With the blood much cleaner, there was significantly better cell function.
Read the abstract » | (added 2011-07-26)
Tags:
-
With a nurse educator, more urgent-start patients choose self-care treatments
As many as half of people start dialysis with no prior plan for it. When a renal triage nurse sees these patients, the chances that they will opt for PD, home HD, or transplant was significantly higher.
Read the abstract » | (added 2011-07-26)
Tags:
-
Changing the treatment options paradigm: Home vs. in-center, not PD vs. HD
Traditional ESRD treatment options education divides the choice into PD vs. HD, and then looks at home HD. Drs. Thodis and Oreopoulos suggest that it makes more sense to look at home (PD and HD) vs. in-center instead.
Read the abstract » | (added 2011-07-26)
Tags:
-
The frontier of regenerative medicine—what it can mean for kidney disease
While dialysis can remove wastes and excess water from the blood, it can't replace or respond to hormones like healthy kidneys do. Regenerative medicine is at the cutting edge of efforts to grow kidney cells in the lab—with the goal of one day growing new kidneys. And, that day may not be far off.
Read the abstract » | (added 2011-07-26)
Tags: Chronic kidney disease
-
Choosing PD may mean fewer access procedures for you
In a study of 369 Canadians with ESRD, 224 (61%!) chose PD, and just 145 (39%) chose HD. After an average of 1.3 years, those who chose PD had significantly fewer access procedures. PD catheters were less likely to fail than HD access.
Read the abstract » | (added 2011-07-26)
Tags:
-
Pilot results of a wearable artificial kidney
Eight people on HD have now tested a new wearable HD device for 4-8 hours. Fluid was removed with no heart problems, and some wastes were removed as well. The safety devices for needle disconnection and clotting worked quickly. A step forward!
Read the abstract » | (added 2011-06-21)
Tags:
-
Risk factors linked to renal cell cancer (RCC) after long-term dialysis
RCC occurs at higher rates in those who have been on dialysis for many years. If you know the risk factors, you can ask for screening. Those at highest risk in a large study were men; older people; ESRD caused by an obstruction, FSGS, or tuberous sclerosis; and those whose kidneys grew new cysts.
Read the abstract » | (added 2011-06-21)
Tags:
-
Statin use may boost PD survival
A new study from Korea has found that taking a statin drug to lower cholesterol helped people on PD live longer—whether or not they had diabetes. The researchers suggest that larger, randomized studies are now needed.
Read the abstract » | (added 2011-06-21)
Tags:
-
NAC protects PD membrane from sugar damage in rats
Over time, caramelized sugars in PD fluid can scar the peritoneal membrane to the point where PD may no longer work. In a rat study, an antioxidant (N-acetylcysteine, or NAC) reduced this damage. NAC may one day prove to be a treatment for humans.
Read the abstract » | (added 2011-06-21)
Tags:
-
Fresenius options education program boosts PD & venous access use
The 3,165 people who attended a treatment options program (TOPs) were more than 8 times more likely to choose PD than those who didn't attend—and twice as likely to get a fistula or graft if they chose HD. TOPs attendees were also more likely to survive the first 90 days of treatment.
Read the abstract » | (added 2011-06-21)
Tags: